Author:
Gruszewska Ewa,Chrostek Lech
Reference34 articles.
1. Arif S, Haq N, Hanif R, Khan AS, Rehman J, Mufti TA. Variations of serum sialic acid levels in liver cirrhosis. J Ayub Med Coll Abbottabad. 2005;17(3):54–7.
2. Barkal A, Di Cesare JL. Influence of sialic acid groups on the retention of glycosphingolipids in blood plasma. Biochim Biophys Acta. 1975;398(2):287–93.
3. Beatty P, Hanisch FG, Stolz DB, Finn OJ, Ciborowski P. Biochemical characterization of the soluble form of tumor antigen MUC1 isolated from sera and ascites fluid of breast and pancreatic cancer patients. Clin Cancer Res. 2001;7(3):781–7.
4. Blomme B, Steenkiste C, Callewaert N, Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol. 2009;50(3):592–603.
5. Bork K, Horstkorte R, Weidemann W. Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway. J Pharm Sci. 2009;98(10):3499–508.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The concentration of total sialic acid in chronic hepatitis B and C;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2018-08-16